Literature DB >> 25895827

Therapy: Retreatment of HCV infection in DAA nonresponders.

Katrina Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25895827     DOI： 10.1038/nrgastro.2015.67

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed.

Authors:  Stanislas Pol; Mark S Sulkowski; Tarek Hassanein; Edward J Gane; Lin Liu; Hongmei Mo; Brian Doehle; Bittoo Kanwar; Diana Brainard; G Mani Subramanian; William T Symonds; John G McHutchison; Ronald G Nahass; Michael Bennett; Ira M Jacobson
Journal:  Hepatology       Date:  2015-05-20       Impact factor: 17.425
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.